Author

Jamie L. Blauvelt

Moffitt Cancer CenterORCID 0000-0002-4529-7990Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Ahmad A. TarhiniiD· 1 shared Alex Alfaro· 1 shared Alyssa ObermayeriD· 1 shared Amod SarnaikiD· 1 shared Divya Priyanka Talada· 1 shared Dorina AvramiD· 1 shared Dung-Tsa Chen· 1 shared Eduardo DavilaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Ahmad A. TarhiniORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BCL11B targeting in tumor CD8+ T cells amplifies anti-tumor response by blocking exhaustion while promoting stemness and cytotoxicity

Leonardo Silvane, Τόμας Ζελένκα, Divya Priyanka Talada, Valeriu Bogdan Cismasiu, Shamima Islam, Raghwendra P. Singh, Zefanias Ngove, Sayan Chakraborty, MacLean S. Hall, Jamie L. Blauvelt, Erika Adriana Eksioglu, Soraya Zorro Manrique, Joseph Johnson, Alyssa Obermayer, Alex Alfaro, , Dorina Avram

This paper shows that reducing BCL11B in CD8+ T cells enhances anti-tumor response by preventing exhaustion and boosting stemness and cytotoxicity.

bioRxiv · Aug 7, 2026 · PreprintImmunology